Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 06, 2015 5:53 PM ET


Company Overview of Glaxosmithkline (China) Investment Co. Ltd.

Company Overview

Glaxosmithkline (China) Investment Co. Ltd. operates as a pharmaceutical holding company in China. It engages in the development, marketing, and services in pharmaceutical products. Glaxosmithkline (China) Investment Co. Ltd. was formerly known as SmithKline Beecham (China) Investment Co., Ltd. As a result of acquisition of SmithKline Beecham (China) Investment Co., Ltd. by GlaxoSmithKline plc, SmithKline Beecham (China) Investment Co., Ltd.'s name was changed. The company was founded in 1998 and is based in Beijing, China. As of 2001, Glaxosmithkline (China) Investment Co. Ltd. operates as a subsidiary of GlaxoSmithKline plc.

Room 901 Building A

Ocean International Centre

No.56 Mid 4th East Ring Road

Chaoyang District

Beijing,  100025


Founded in 1998


86 10 5925 2888


86 10 5925 2999

Key Executives for Glaxosmithkline (China) Investment Co. Ltd.

Glaxosmithkline (China) Investment Co. Ltd. does not have any Key Executives recorded.

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Glaxosmithkline (China) Investment Co. Ltd., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at